EX-2.3
from 8-K
1 page
July 24, 2003 Dr. James E. Skinner 399 Autumn Drive Bangor, Pa 18013 Dear Skip: I Am Writing With Respect to the Purchase and Royalty Agreement That Was Made and Entered Into on October 24th 2002 by and Between Vicor and You. Section B of the Agreement States as Follows, "B. Except as Otherwise Provided Herein, the Purchase Price Shall Be Paid as Follows: (1) $50,000 Upon the Execution of This Agreement by Both Parties, (2) $50,000 on the Earlier to Occur of (A) Vicor's Receipt of 510-K Approval by the Food and Drug Administration for the Cardiac Device, or (B) June 30th 2003, and (3) $150,000 on the Earlier to Occur of (A) Vicor's Receipt of Sufficient Funds From the Sale or Licensing of the Cardiac Device or Other Activities to Allow Vicor to Make This Payment, or (B) September 30th 2003." We Are Taking the Necessary Steps to Attempt to Complete Our Fund Raising Through Institutional Investors as Well as Other Means; However, That Process Will Extend Beyond September 30th 2003. Accordingly, I Am Writing to Modify the Purchase and Royalty Agreement Section B (2) and Substitute in Its Place the Following: B. (2) (A) $10,000 Upon Vicor's Receipt of the $500,000 Investment From the Astri Group, (B) $20,000 Upon Vicor's Receipt of $1,000,000 in Additional Investment Funds, (C) $20,000 Upon Vicor's Receipt of an Additional $1,000,000 in Investment Funds. Dr. James E. Skinner Page 2 of 2 July 24, 2003 Please Indicate Your Agreement to This Modification by Signing Where Provided Below and Returning This Agreement to Me as Quickly as Possible. Cordially Yours, /S/ David H. Fater - By: David H. Fater Its: Chief Executive Officer Dhf/Dw the Changes and Reasons to the Purchase and Royalty Agreement That Are Discussed in This Letter Will Be Reflected in a Written Amendment Signed by Both Parties. Accepted and Agreed to This 24 Day of July, 2003, by James E. Skinner and Vicor Technologies, Inc. /S/ James E. Skinner - By: James E. Skinner
12/34/56
